Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Gilead Sciences
Gilead Sciences
Bristol-Myers gets the approval Gilead didn't want: Daklinza + Sovaldi for hep C
Fierce Pharma Marketing
Wed, 08/27/14 - 10:19 am
Bristol-Myers Squibb
Gilead Sciences
hepatitis C
Daklinza
Sovaldi
Gilead, Jazz Among 4 Top Big Cap Medicals To Watch
Investors.com
Wed, 08/27/14 - 09:56 am
Jazz Pharmaceuticals
Gilead Sciences
Illumina
Salix
Why Gilead Sciences (GILD) Could Beat Earnings Estimates Again
Yahoo/Zacks.com
Fri, 08/22/14 - 12:06 pm
Gilead Sciences
earnings
Gilead (GILD) Hits 52-Week High Thanks to Sovaldi
Yahoo/Zacks.com
Thu, 08/21/14 - 09:43 am
Gilead Sciences
Sovaldi
hepatitis C
UK Says Sovaldi Is Worth It. We Should Listen.
Forbes
Mon, 08/18/14 - 09:20 am
UK
Sovaldi
hepatitis C
Gilead Sciences
Gilead says wins favorable ruling on hep C drug
Yahoo/Reuters
Fri, 08/15/14 - 11:42 am
hepatitis C
Gilead Sciences
Roche
Sovaldi
UK Recommends Covering Sovaldi Hepatitis C Pill
WSJ Pharmalot
Fri, 08/15/14 - 05:19 am
UK
Sovaldi
hepatitis C
Gilead Sciences
How Gilead Sciences Became A Big Name In Biotech
Investopedia
Tue, 08/12/14 - 08:31 am
Gilead Sciences
Gilead bags a portfolio of HIV-neutralizing antibodies
Fierce Biotech
Wed, 07/30/14 - 06:37 pm
Gilead Sciences
antibodies
HIV
Despite outcry over cost, breakthrough drug becomes treatment of choice for hepatitis C
Yahoo/AP
Tue, 07/29/14 - 09:35 am
hepatitis C
Sovaldi
Gilead Sciences
5 Huge Biotech Catalysts Right Around the Corner for Top Stocks
24/7 Wall St
Mon, 07/28/14 - 12:26 pm
Arrowhead Research
Gilead Sciences
Intercept Pharmaceuticals
Amgen
Vertex Pharmaceuticals
RNAi
Kyprolis
VX-661
Sovaldi
Kalydeco
Politicizing Gilead's Research And Development Costs For Sovaldi Is A Reckless And Dangerous Misadventure
Forbes
Sat, 07/26/14 - 09:56 am
Sovaldi
Gilead Sciences
hepatitis
hepatitis C
Can Gilead break into cancer? With Zydelig approval, it gets its chance
Fierce Pharma
Fri, 07/25/14 - 09:16 am
Gilead Sciences
Zydelig
PI3k inhibitor
Roche
Biotech Giant Blows Away Expectations After Selling $3.5 Billion Of Its 'Wonder Drug'
Yahoo/Business Insider
Thu, 07/24/14 - 08:35 am
Gilead Sciences
Sovaldi
earnings
Gilead Sciences Beats Earnings Forecasts, Sovaldi Sales Strong, Shares Slump
Barron's
Wed, 07/23/14 - 06:09 pm
Gilead Sciences
earnings
Sovaldi
FDA approves Gilead Sciences' Zydelig for 3 forms of blood cancer
Yahoo/AP
Wed, 07/23/14 - 04:33 pm
FDA
Zydelig
Gilead Sciences
chronic lymphocytic leukemia
follicular lymphoma
small lymphocytic lymphoma
Gilead Sciences: Sovaldi’s a Blockbuster, the Question is How Big
Barron's
Mon, 07/21/14 - 11:01 am
Gilead Sciences
Sovaldi
hepatitis C
Hepatitis C Spurs Unusual Patent Wars Among Big Drug Makers
WSJ Online
Mon, 07/21/14 - 10:35 am
patents
hepatitis C
Gilead Sciences
Merck
AbbVie
Roche
CVS officials say Sovaldi pricing in line with history, but unsustainable
Marketwatch
Mon, 07/21/14 - 10:15 am
CVS
Sovaldi
Gilead Sciences
hepatitis C
Top Biotech Earnings Previews for the Week Ahead
24/7 Wall St
Mon, 07/21/14 - 09:20 am
earnings
Cubist Pharma
Gilead Sciences
Biogen Idec
Celgene
Illumina
Alexion
Pages
« first
‹ previous
…
71
72
73
74
75
76
77
78
79
…
next ›
last »